Aflac Incorporated (AFL)

Over the past six months, Aflac's stock has seen a gain of 16.1%, outperforming the Finance sector and the S&P 500. Key events impacting the stock price include strong U.S. business and product launches, a solid financial position and capital deployment, Q1 2025 financial results, a cybersecurity incident, and analyst ratings. Aflac reported a decrease in total revenues to $3.4 billion in Q1 2025, primarily due to net investment losses. On June 20, 2025, Aflac disclosed a cybersecurity incident affecting customer personal information, leading to a 1.3% fall in Aflac's shares in premarket trading. Raymond James maintained an "Outperform" recommendation for Aflac on May 29, 2025.

The provided search results do not contain specific information about the demand seasonality for Aflac, Inc.'s products and services. General economic conditions can influence the demand for supplemental, discretionary insurance products. An economic downturn could adversely affect the demand for such products, particularly for companies like Aflac that distribute supplemental insurance primarily through the worksite.

Aflac, Inc. is an American insurance company specializing in supplemental health and life insurance products, operating primarily in the United States and Japan. The company provides voluntary supplemental health and life insurance that pays cash benefits directly to policyholders who experience illness or injury. Aflac's major products include cancer insurance, medical insurance, accident insurance, short-term disability insurance, critical illness insurance, hospital indemnity insurance, dental insurance, vision insurance, life insurance, and other products in Japan. Aflac distributes its products through various channels, including independent agents, brokers, and directly to consumers and businesses.

Aflac's primary geographic markets are the United States and Japan, operating through Aflac Japan and Aflac U.S. Aflac Japan's total assets accounted for 78% of the company's total assets as of March 31, 2025. Aflac Japan is the leading insurer in Japan for cancer and medical policies in force. In the U.S., Aflac is the number one provider of supplemental health insurance products.

Aflac has maintained a strong brand reputation, being recognized as one of the "World's Most Ethical Companies" for the 19th consecutive year in 2025 by Ethisphere. However, a recent cybersecurity incident disclosed on June 20, 2025, affecting customer personal information, could potentially impact Aflac's reputation.

Aflac Incorporated has significant institutional ownership, with institutions holding approximately 67.31% to 69% of the company's shares. Major institutional owners include Japan Post Holdings Co., Ltd., Vanguard Group Inc, and BlackRock, Inc. Individual ownership accounts for approximately 30% to 45.95% of the company. Daniel P. Amos, the CEO, is a significant individual shareholder.